Targeting Extended Thromboprophylaxis after Surgery Through Multidimensional Dynamic Pulmonary Embolism Risk Assessment: Development and Temporal Validation in 4.8 Million Operations
BACKGROUND: Extended thromboprophylaxis reduces postoperative venous thromboembolism but is inconsistently used because pulmonary embolism (PE) risk varies across operations and may change after discharge. We developed and temporally validated a two-stage calculator to estimate PE risk at discharge and update risk after unplanned readmission or reoperation. STUDY DESIGN: ACS-NSQIP adult operations from 2020-2023 were used for development (n=3,864,605), with 2024 operations reserved for temporal validation (n=956,434). The primary outcome was 30-day postoperative PE. Penalized logistic regression modeled discharge risk using patient, surgical, and early postoperative variables; dynamic reassessment added timing of first unplanned readmission and reoperation. A prespecified 0.5% predicted-risk threshold was evaluated. RESULTS: Among 4,856,597 operations, 17,045 patients developed PE (0.35%). In temporal validation, the discharge model demonstrated AUC 0.811 (95% CI, 0.801-0.818), calibration slope 1.024, and intercept 0.036. Dynamic reassessment improved discrimination to AUC 0.892 (95% CI, 0.887-0.897), with calibration slope 0.991 and intercept 0.030. Among 57,840 patients with an unplanned-return event, reassessment moved 24,320 patients above the 0.5% treatment-consideration threshold despite being below threshold at discharge. This newly flagged group had 711 observed PEs, a 2.92% PE rate, and 1 PE within 30 days for every 34.2 newly flagged patients under usual care. Sensitivity analyses indicated that unplanned-return occurrence, rather than exact postoperative day, was the durable risk signal. CONCLUSIONS: Across adult surgery, dynamic PE reassessment after unplanned readmission or reoperation identifies an actionable high-risk postoperative state not captured at discharge. This surgeon-facing calculator can make extended-prophylaxis reconsideration reproducible when prevention remains possible.
Authors
- Ramsey M. Dallal (ORCID: https://orcid.org/0000-0002-0477-9803)
- Luis H. Eraso
- Geno J. Merli (ORCID: https://orcid.org/0000-0002-8663-6872)
- Michael Li
- Benjamin Moran
- Jeffrey Riggio
Institutions
- Thomas Jefferson University (US)
- Thomas Jefferson University Hospital (US)
- Sidney Kimmel Cancer Center (US)
Publication Details
- Journal
- Journal of the American College of Surgeons
- Published
- 2026-06-19
- DOI
- https://doi.org/10.1097/xcs.0000000000002074
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00